Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Mar 22.
Published in final edited form as: Clin Psychol Sci. 2019 Mar 29;7(4):840–855. doi: 10.1177/2167702619830404

Group- versus Parent-Involvement CBT for Childhood Anxiety Disorders: Treatment Specificity and Long-term Recovery Mediation

Wendy K Silverman 1, Carla E Marin 1, Yasmin Rey 2, William M Kurtines 2, James Jaccard 3, Jeremy W Pettit 2
PMCID: PMC7984418  NIHMSID: NIHMS1519326  PMID: 33758679

Abstract

Objective:

Treatment specificity and long-term recovery mediation of peer-involvement group cognitive behavioral therapy (GCBT) and parent-involvement CBT (PCBT) were investigated for youth anxiety disorders.

Method:

240 youths with primary anxiety diagnoses participated in a randomized controlled efficacy trial. Youth anxiety and peer variables/mediators (positive peer-youth relationships; social skills), and parent variables/mediators (psychological control; negative parent-youth relationships) were assessed.

Results:

At posttreatment and 12-month follow up, positive peer-youth relationships were significantly higher in GCBT than PCBT (specificity). At posttreatment, not follow up, parental psychological control was significantly lower in PCBT than GCBT (specificity). Parental psychological control and positive peer-youth relationships were putative mediators. The two CBTs produced similar anxiety reductions through different mechanisms.

Conclusions:

CBT targets show specificity and mediation, providing insight into specific mechanisms through which GCBT and PCBT bring about anxiety reduction and guidance for streamlining these CBTs in practice.

Keywords: youth anxiety, CBT, specificity, mediation, mechanisms


Cognitive behavioral therapy (CBT) is the most well-researched and strongest evidence-based psychological treatment for anxiety disorders in children and adolescents (referred to as ‘youth’ unless referring to a specific subgroup) (e.g., Higa-McMillan, Francis, Rith-Najarian, & Chorpita, 2016; Silverman, Pina, & Viswesvaran, 2008). Since Kendall’s (1994) seminal study demonstrating the efficacy of youth-focused individual CBT (ICBT), peer-based group cognitive behavioral therapy (i.e., GCBT) (e.g., Silverman et al., 1999) and parent-involvement cognitive behavioral therapy (i.e., PCBT) (Kendall, Hudson, Gosch, Flannery-Schroeder, & Suveg, 2008; Silverman, Kurtines, Jaccard, & Pina, 2009) were developed, tested, and shown to be similarly efficacious (e.g., Breinholst, Esbjorn, Reinholdt-Dunne, & Stallard, 2012; Silverman et al., 2008; Thulin, Svirsky, Serlachius, Andersson, & Ost, 2014).

Unfortunately, randomized clinical efficacy trials that aim to advance understanding of mechanisms to explain how change is produced are scarce, despite calls for explanatory-efficacy trials for over two decades (Gaynor, 2017; Kazdin, Bass, Ayers, & Rodgers, 1990; Kendall, Olino, Carper, & Makover, 2017; Silverman & Kurtines, 1997; Weersing & Weisz, 2002). In this article, we present an explanatory-efficacy trial for youth anxiety disorders, focusing on GCBT and PCBT. Both are well-supported and yield similar medium effect sizes (e.g., Silverman et al., 2008). As such, we hypothesized both CBTs will produce statistically significant changes on the study’s outcomes. We moved beyond efficacy outcome analysis to advance understanding about whether variables targeted in GCBT and PCBT are specific to each treatment, and whether these variables in turn produce youth anxiety reduction, including long-term recovery mediation and patterns of directionality of change (e.g., La Greca, Silverman, & Lochman, 2009). The variables we targeted in GCBT and PCBT are emphasized in theoretical models of the development and maintenance of anxiety and its disorders in youth. These extensively studied models highlight the critical role of peer relationship functioning and problematic social skills, and parental psychological control (i.e., behaviors that inhibit youths’ psychological and emotional development) and parent-youth relationships (e.g., Chorpita & Barlow, 1998; Ginsburg, Silverman, & Kurtines, 1995; La Greca & Landoll, 2011; Motoca, Williams, & Silverman, 2012). Below we present background literature, the study’s main research questions, and hypotheses.

Do GCBT and PCBT Produce Treatment Specific Effects on Targeted Variables?

GCBT and PCBT emphasize graded exposures to anxiety-provoking situations and cognitive strategies (e.g., Kendall et al., 2008; Silverman et al., 1999; Silverman et al., 2009). Each treatment targets distinct variables: peer variables in GCBT; parent variables in PCBT. Treatment specific effects, or “treatment specificity,” addresses whether changes produced in targeted variables are indeed because of the specific therapeutic procedures contained/delivered in each treatment. Support for treatment specificity would suggest that mechanisms underlying therapeutic change can be explained by that specific procedure delivered in each treatment, opening critical new lines for further mechanism-based research, and providing critically-needed data to support the procedure’s inclusion/delivery. Data showing that specific variables change irrespective of targeting would suggest otherwise, supporting the notion that other mechanisms are likely involved in therapeutic outcome and raising questions about continued the procedure’s inclusion/delivery.

Studies on treatment specificity are extremely rare in child and adolescent randomized clinical efficacy trials, including anxiety. Kolko, Brent, Baugher, Bridge, and Birmaher (2000), one of the few and earliest studies, found no evidence of treatment specificity for cognitive variables and family variables despite their respective targeting in CBT and family therapy. In youth anxiety, we found only one behavioral therapy efficacy trial. This was a comparison of Social Effectiveness Therapy for Children with social phobia (SET-C; N = 67) with Testbusters (control) (Beidel, Turner, & Morris, 2000). SET-C targeted social skills and performance skills; Testbusters did not. Treatment specificity was not found, with one exception: children in SET-C showed higher observer-rated social skills than children in Testbusters, pretreatment to posttreatment.

We found only three youth anxiety efficacy trials that examined whether treatment specificity occurs when parent variables are targeted in PCBT, but not ICBT (Jongerden & Bögels, 2014, N=104; Kendall et al., 2008, N=161; Silverman et al., 2009, N=119). Parent variables targeted were parenting skills and parent-child relationships. Treatment specificity was not found in any of these trials: parent variables significantly improved in PCBT, when targeted, but also in ICBT when not targeted, pretreatment to posttreatment.

In the present efficacy trial, we investigated whether GCBT, which targeted peer variables changes those peer variables specifically, but PCBT does not; and whether PCBT, which targeted parent variables changes those parent variables specifically, but GCBT does not. Because the targets were clearly distinctive in the two CBTs, our first hypothesis was that GCBT, not PCBT, would produce treatment specificity effects on positive peer-youth relationships and youth social skills at posttreatment, as these were the variables targeted. Our second hypothesis was that PCBT, but not GCBT, would produce treatment specificity effects on perceived parental psychological control and negative parent-youth relationships at posttreatment, as these were the variables targeted. We also explored whether these treatment specificity effects would be maintained at 12-month follow up.

Do Peer Variables Targeted in GCBT and Parent Variables Targeted in PCBT Mediate Anxiety Treatment Outcome and/or Long-term Recovery, and is the Directional Pattern of Change from Targeted Variables to Anxiety Reduction?

Research on treatment mediation is rare, including in youth anxiety, despite calls for such research (e.g., Kazdin et al., 1990; La Greca et al., 2009; Weersing & Weisz, 2002; Weisz et al., 2017). Most trials focus on a single variable; in youth anxiety studies, cognitive variables are most often examined as mediators (Peris et al., 2015; Treadwell & Kendall, 1996), though a recent study examined somatic symptoms (Hale et al., 2018). Further, most studies focus on pre-to posttreatment analysis only. A rare exception is from the Child Anxiety Multimodal Study (Walkup et al., 2008), which focused again on cognitive variables as mediators of ICBT recovery at three-month follow up, with supportive results (Kendall et al., 2016).

For the variables of interest in our study, only one efficacy trial focused on peer variables (Alfano et al., 2009). Findings suggested youth self-rated loneliness may be a mediator of SET-C outcome. Two efficacy trials examined parent variables’ mediational role in PCBT long-term recovery at one-year follow up (Settipani, O’Neil, Podell, Beidas, & Kendall, 2013; Silverman et al., 2009). In Silverman et al. (2009), no evidence was found that either youth or parent ratings of parent variables mediated anxiety recovery, though interesting patterns of directionality emerged (discussed below). Settipani et al. (2013) found youth ratings of parental psychological control and family affective involvement significantly mediated recovery.

In the present randomized clinical efficacy trial, we examined peer variables (positive peer-youth relationships, youth social skills) and parent variables (parental psychological control, negative parent-youth relationships) as mediators of long-term recovery at 12-month follow up. All variables were assessed from perspectives of youth and parents, thus, in all instances we are assessing sources’ perceptions of changes. We also extended past work in ways that aligned with the efficacy trials of Silverman et al. (2009) and Settipani et al. (2013). In almost all past trials, investigators make the plausible and reasonable assumption/hypothesis that the directional pattern of change is from targeted variable (i.e., hypothesized mediator) to outcome. As such, this has been the only directional pattern of change modeled/analyzed. Exceptions are Silverman et al. (2009) and Settipani et al. (2013), who modeled/analyzed whether the directional pattern is from youth anxiety reduction at posttreatment to parent variables at 12-month follow up. Findings revealed directional patterns varied by source and measure. Some showed change in the plausible, hypothesized direction: targeted parent variables at posttreatment were associated with positive changes in youth anxiety outcome at 12-month follow up. Other findings showed the direction was not as hypothesized, but instead was from youth anxiety reduction at posttreatment to changes in parent variables at 12-month follow up. This was true even in ICBT, which was especially unexpected because no parent variables were targeted in this arm.

Thus, in addition to treatment specificity, in the present study we investigated contemporaneous mediation of treatment outcome and mediation of long-term recovery at 12-month follow up for GCBT and PCBT, and directional pattern of change. Investigating these issues is critically important to advance understanding of the complexities of therapeutic change and to pave the way for future research to pursue further mechanism-based research, as well as to improve the design and outcomes of GCBTs and PCBTs. If the data provide evidence of mediation for long-term recovery and in the plausible/assumed direction, then this supports continued targeting of the selected variables. However, if the data suggest the directional pattern of change is from youth anxiety reduction to the peer and parent variables targeted, then greater scrutiny of the mechanisms underlying this change is needed, and it also raises questions about whether these variables ought to be targeted in future research and clinical work. Consistent with our expectation of treatment specificity effects, we hypothesized that the peer variables targeted in GCBT would have larger mediated effects on anxiety reduction at posttreatment and 12-month follow up (long-term recovery) in GCBT than PCBT by virtue of larger mean differences on the peer variables in GCBT versus PCBT. We hypothesized that the parent variables targeted in PCBT would have larger mediated effects on anxiety reduction at posttreatment and 12-month follow up (long-term recovery) in PCBT than in GCBT by virtue of larger mean differences on the parent variables in PCBT versus GCBT.

Method

Participants

Two hundred forty youths (ages 7 to 16 years; M = 9.81 yrs; SD = 2.28) and their parents (mothers) who presented to a youth anxiety disorders specialty research university clinic enrolled in this randomized efficacy clinical trial (ClinicalTrials.gov identifier: CT00073645). See Figure 1 for CONSORT diagram. Pediatricians, school psychologists, and other professionals were major referral sources. One hundred eighty-three (76.3%) completed treatment, comparable to most past efficacy trials (Silverman et al., 2008). To be eligible for inclusion in the trial, all youths were required to meet criteria for a primary Diagnostic and Statistical Manual of Mental Disorders-4th Edition (DSM-IV; American Psychiatric Association, 1994) anxiety disorder using the Anxiety Disorders Interview Schedule for Children (Child and Parent Versions) (ADIS-IV: C/P; Silverman & Albano, 1996). Primary diagnoses were separation anxiety disorder (41.3%), social phobia (25.4%), specific phobia (15.4%), generalized anxiety disorder (13.3%), and other anxiety disorders (4.6%). Exclusion criteria were developmental disabilities, psychosis, or current involvement in another psychosocial treatment. A small proportion was on a stable dose of serotonin reuptake inhibitors (10% GCBT; 6% PCBT). One hundred eighty (75%) were Hispanic/Latino, 47 (19.6%) European American, 7 African American (2.9%), and 6 (2.5%) reported “other” ethnicity or race. Fourteen percent had an annual family income of less than $20,000, 20% between $21,000 and $40,000, 15% between $41,000 and $60,000, 12% between $61,000 and $80,000, 10% between $81,000 and $100,000, 12% between $101,000 and $149,000, and 9% over $150,000. Eight percent of mothers did not report income. Seventy four percent of mothers were married, 2% single, 12% divorced, 6% separated, 0.5% widowed, and 2.5% cohabitating with partner. Three percent of mothers did not report marital status.

Figure 1.

Figure 1.

CONSORT diagram flowchart

Measures

Diagnostic Instrument Administered to Youth and Parents

ADIS-IV: C/P (Silverman & Albano, 1996).

Independent evaluators (IEs) administered the ADIS-IV: C/P to youths and parents, respectively. Before administering the ADIS-IV: C/P, IEs received extensive training in administration and scoring protocol and met 100% reliability criterion on five videotaped child–parent assessments. The ADIS-IV: C/P yields retest reliability kappas between .80 to .92 for combined diagnoses (e.g., Silverman, Saavedra, & Pina, 2001), and significant associations with youth anxiety ratings (e.g., Wood, Piacentini, Bergman, McCracken, & Barrios, 2002). We also collected two-week retest reliability data in the present sample by administering the ADIS-IV: C/P twice over two weeks to 20% of participants; kappa coefficients were .77 or higher on the primary targeted diagnosis. The disorder most interfering/impairing was ‘primary’ and was targeted in treatment.

Primary Outcome Measure Completed by Youths and Parents

Revised Children’s Manifest Anxiety Scale (RCMAS; Reynolds & Richmond, 1978).

The RCMAS, child and parent versions (RCMAS/P), are 37-item rating scales that assess anxiety symptom severity, with extensive reliability and validity data (Reynolds & Richmond, 1978), including extensive data showing it is sensitive to change in clinical trials (Silverman & Ollendick, 2005). All items are rated either Yes (1) or No (0). Total Anxiety scores range from 0 to 28, with higher scores indicating higher levels of severity. The parent version (RCMAS/P) is reworded from, “I…” to “My child…,” with the identical stems, as done in past studies (e.g., Kendall, 1994; Silverman et al., 1999). In this sample, the alpha coefficient was .84 for the RCMAS and .78 for the RCMAS/P.

Clinically Significant Change Measures

ADIS-IV: C/P (ADIS-C/P; Silverman & Albano, 1996).

Whether participants met diagnostic criteria for the primary targeted diagnosis at posttreatment (i.e., Recovered, Not Recovered) was one measure of clinically significant improvement. IEs were masked to participants’ treatment arm and pretreatment diagnoses.

CBCL-Internalizing (CBCL-I; Achenbach, 1991).

A minimum criterion T-score of less than 65 on the parent-completed CBCL-I broadband scale, adjusted according to age norms (e.g., Kendall, 1994; Silverman et al., 1999) was used for normative comparisons.

Children’s Global Assessment Scale (C-GAS; Shaffer et al. 1983).

The C-GAS is a 1- to 100-point clinician rating scale that assesses functional impairment. Scores < 67 are viewed as in the clinical range (Shaffer et al., 1983). All case conference attendees (including study directors, therapists, and IEs) were masked to participants’ identity, status, and assessment point to reduce rater bias (Bird et al., 1993; Dyrborg et al., 2000). IEs’ ratings during case conference meetings were used to establish inter-rater reliability. Intraclass correlation coefficients in the current study ranged from .93 to .99 across pre, post and 12-month follow up.

Peer Measures Completed by Youths and Parents

Friendship Questionnaire - Positive Interactions (FQ-PI; Bierman & McCauley, 1987).

The FQ, child and parent versions (FQ/P) are 36-item rating scales designed to assess peer-youth relationships. All items are rated on a 1 (none of the time, never) to 5 (all of the time, always) point scale. Scores on the Positive Interactions (PI) subscale of the FQ range from 0 to 80, with higher scores indicating higher levels of positive peer interactions. The parent version is reworded from, “I…” to “My child…,” as done in past research; with the identical stems, as done in past research (e.g., Flannery-Schroeder and Kendall, 2000; Motoca et al., 2012). The FQ-PI discriminates between positive and rejected/neglected social status, and correlates significantly with parent and teacher ratings of social competence (Bierman & McCauley, 1987). In this sample, the alpha coefficients for youth and parent versions were .85 and .89, respectively.

Social Skills Rating System (SSRS; Gresham & Elliott, 1990).

The SSRS is a 34-item (youth), 38-item (parent) rating scale system that assesses levels of youth social skills. All items are rated on a 0 (Never) to 2 (Very Often) point scale. Scores range from 0 to 68 for the youth scale and 0 to 76 for the parent scale, with higher scores indicating higher levels of social skills. Extensive data support the SSRS’s reliability and validity (Gresham & Elliot, 1990). In this sample, the alpha coefficients for youth and parent versions were .86 and .89, respectively.

Parent Measures Completed by Youths and Parents

Parenting Behavior Inventory - Parental Psychological Control (CRPBI/PRPBI-PC; Schludermann & Schludermann, 1970).

The CRPBI/PRPBI is a 30-item rating scale that assesses perceived parents’ behaviors toward the youth, from the perspective of youth and parent, respectively. All items are rated on a 0 (Not like) to 2 (A lot like) point scale. The Psychological Control (PC) subscale consists of 10 items and scores range from 0 to 20; higher scores indicate higher levels of perceived PC. Coefficient alphas between .76 and .82 have been reported for different informants (Schwarz, Barton-Henry, & Pruzinsky, 1985). In this sample, the alpha coefficients were .79 for youth PC and .72 for parent PC ratings.

Conflict Behavior Questionnaire - Negative Parent-Youth Relationship (CBQ-NPYR; Prinz, Foster, Kent, & O’Leary, 1979).

The CBQ is a 42-item rating scale that assesses conflict in the parent-youth relationship. All items are rated either True (1) or False (0). Scores on the Negative Parent-Youth Relationship (NPYR) subscale range from 0 to 16, with higher scores indicating higher levels of negativity in the parent-youth relationship. Reliability and validity data have been documented (e.g., Robin & Foster, 1989). In this sample, the alpha coefficients for youth and parent CBQ-NPYR ratings were .75 for both.

Procedure

The study received human ethics approval from the university’s institutional review board. All parents and youths provided informed consent/assent prior to participation in the trial’s procedures. All measures were completed at pretreatment, posttreatment, and 12-month follow up. Youths who met study inclusion were randomly assigned to either GCBT or PCBT in blocks of seven to avoid delay in the formation of groups. Each treatment contained 12 to 14 weekly sessions of 60 minutes in duration. Treatment manuals were developed for each to standardize all treatment sessions. Nineteen child groups comprised the GCBT arm, with each group consisting of 4 to 8 youths (with most having 5 to 6 youths). There were no significant differences in the proportion of primary anxiety diagnosis contained in GCBT and PCBT (Chi square = .98; p =.99).

CBT Involving Peer Group (GCBT).

GCBT targeted youth anxious symptoms in a peer-group format using in- and out-of-session exposures and CBT strategies. GCBT contained a heterogeneous set of anxiety diagnoses, with subgroups of 2 to 3 youths formed to conduct the in-session exposures (e.g., Lumpkin, Silverman, Weems, Markham, & Kurtines, 2002; Silverman et al., 1999). For example: children with social phobia in a subgroup would each be asked to read in front of the other subgroup members, give a speech, etc.; parents of children with separation anxiety disorder would each be asked to leave the clinic for a certain duration; dogs would be brought to sessions for dog-exposures for those with specific phobia of dogs; and children with generalized anxiety disorder would practice cessation of reassurance seeking in their subgroup. GCBT also targeted increasing (1) positive peer-youth relationships and (2) youth social skills. To address (1), therapists assisted youths in identifying positive peer-youth behaviors (e.g., getting together with a peer) and then modeled and conducted role plays. To address (2), therapists modeled and conducted role plays using specific social skills that were taught in session (e.g., increase eye contact, dispense and receive compliments). For both (1) and (2) youths were encouraged to participate and to provide peer feedback, particularly after role plays. Of note, GCBT contained three brief parent-group meetings, about 15 minutes in duration, led by the same therapists of the youth groups. The purpose of the parent meetings was to provide information about GCBT’s goals and procedures and to advise parents that on occasion they might need to transport their child to an exposure task (e.g., a peer’s home). No instructions or prescriptions were provided to parents in these meetings especially about their child’s peer interactions or social skills. The parent meetings were held at GCBT start, middle, and end, as in Barrett (1998), Flannery-Schroeder and Kendall (2000), and Silverman et al. (1999). Importantly, GCBT involved no training or instruction with parents particularly with respect to any of the PCBT’s targeted variables.

CBT Involving Parents (PCBT).

PCBT targeted youth anxious symptoms in a parent-youth dyadic format using in- and out-of-session exposures and CBT strategies. Similar exposures as those noted above were used in PCBT, but with the parent present, or parent would be asked to leave the session room and clinic in cases of separation anxiety disorder. PCBT also targeted decreasing (1) negativity/conflict in parent-youth relationships and (2) parental psychological control. To address (1), therapists assisted youths and parents in identifying negativity/conflict in the parent-youth relationship (e.g., youth noncompliance to parental requests). This was followed by communication and problem-solving skills training. To address (2), therapists assisted youths and parents in identifying parental psychological control behaviors (e.g., parent guilt induction, lack of autonomy granting) for targeting. Therapists modeled and conducted role plays to identify and decrease these parental behaviors. Importantly, PCBT involved no training or instruction with parents with respect to any of the GCBT’s targeted variables. For example, although some youths in PCBT were asked to conduct out-of-session exposures that might involve peers, such as giving a brief classroom presentation, parents were not instructed in how to improve their child’s skills to successfully complete this exposure task.

Treatment Integrity.

Treatment sessions were video recorded; therapists were unaware of the sessions that would be assessed. IEs, not involved in the study, rated a randomly selected 20% of videotapes on a checklist, derived from past studies (Silverman et al., 1999; Silverman et al., 2009). Ratings for the targeting of peer variables yielded 100% present in GCBT; 0% present in PCBT. Ratings for the targeting of parent variables yielded 100% present in PCBT; 0% present in GCBT. There was little chance of cross-contamination across treatments given the highly distinctive nature of the group versus parent work. Further, both treatments were manualized and carefully supervised, by the first author.

Therapists.

Therapists were 8 doctoral level psychology graduate students. Therapists were randomly assigned to cases across arms, as neither required differential skill level and background. The first author provided didactic and clinical training, and weekly supervision. There were no statistically significant differences between any therapists on any outcome, peer, or parent variables at posttreatment and 12-month follow up.

Treatment Non-completion.

The current study was designed as a specificity- and mediation-based efficacy trial that focused only on treatment completers. Given this, differences between completers and non-completers are important to document, especially as a function of treatment arm, which could undermine random assignment. There was no significant difference in non-completion rates across study arms (GCBT = 22.4%; PCBT = 24.8%; z = .44, p > .05), and these non-completion rates are similar to those reported in past efficacy trials (e.g., Kendall, 1994; Silverman et al., 1999). Treatment completers and non-completers were compared using data at pretreatment on all primary outcome and mediator measures, as well as sociodemographics (e.g., youth age, youth sex). There were no statistically significant differences between completers and non-completers on any of these 14 variables, except for parent marital status [χ2 (1) = 17.44, p < .05]. More completers than non-completers were from families where the mothers were in intact marriages. There were no significant differences in marital status by treatment arm.

Because we designed our study as an efficacy trial to test theoretical mechanisms surrounding efficacy of GCBT and PCBT, per protocol analyses were used (e.g., Feinman, 2009; Meuret, Rosenfield, Seidel, Bhaskara, & Hofmann, 2010). Our study was not designed to estimate broader effectiveness of the CBTs nor to identify the effects of treatment adherence on outcomes, which is typically the focus of later stage effectiveness trials and entails systematic efforts to obtain posttreatment data for non-completers. (Flay, 1986; Greenwald & Cullen, 1985; Mitka 2012). Indeed, mediation analysis in an effectiveness study conflates mechanisms associated with treatment efficacy (why is the treatment effective) with mechanisms associated with treatment adherence (why do people not adhere to or complete the treatment), which are theoretically distinct and likely governed by different factors (Feinman, 2009). Both processes are optimally studied separately to avoid confounding. In addition, analyzing data that includes treatment noncompleters (i.e., intent to treat) can yield biased estimates of efficacy-based mediation.

Results

Preliminary Analyses

Non-model and model-based outlier analyses were undertaken; no outliers were found. Due to non-normality in several variables, analyses used a maximum likelihood estimator with robust standard errors as implemented in the MPlus 7.0 statistical software (option MLR; Muthén & Muthén, 2012). Missing data bias was assessed by creating a dummy variable to indicate presence or absence of missing data on each variable. Associations between dummy variables and other study variables were examined. No significant associations were observed. There were no statistically significant differences at pretreatment between families in GCBT and families in PCBT on demographic variables, primary diagnosis, medication usage, and scores on any of the anxiety, peer, or parent variables. Missing data were accommodated using full information maximum likelihood (Enders, 2010). Because GCBT contained 19 separate treatment groups, modeling incorporated adjustments for clustering effects (Baldwin, Murray, & Shadish, 2005) using cluster algorithms in MPlus. Participants in PCBT were grouped as one cluster, yielding a total of 20 clusters across arms. As a check on specification error, exploratory analyses tested for interactions between the treatment arm and the baseline measures of the outcome and mediators; none of these were statistically significant and they are not considered further.

Outcome Analyses

Initial analyses compared outcome means to baseline means to determine whether anxiety reduction occurred in the treatment arms. The correlations between the parent and youth ratings were low. For example, the correlation between the parents’ ratings of youth anxiety and youths’ self-ratings of anxiety was .14 at pretreatment and .29 at posttreatment. These modest correlations between parent and child ratings are typical of past research (Silverman et al., 2009). We therefore treated each source’s ratings as separate primary outcome measures.

Primary outcomes.

There was statistically significant pretreatment to posttreatment mean change on the RCMAS in GCBT (pretreatment mean = 12.93, SD = 6.59, posttreatment mean = 7.56, SD = 5.85, Cohen’s d = 0.73), and in PCBT (pretreatment mean = 13.56, SD = 6.62, posttreatment mean = 7.33, SD = 5.85, Cohen’s d = 1.03). This also was true for the RCMAS/P (GCBT pretreatment mean = 12.96, SD = 5.71, posttreatment mean = 8.42, SD = 5.79; Cohen’s d = 0.85; PCBT pretreatment mean = 12.69, SD = 5.54, posttreatment mean = 8.04, SD = 5.63, Cohen’s d = 0.85). The changes for GCBT were not significantly different from the changes for PCBT, suggesting the effects for the two treatments were comparable. However, parent ratings of youth anxiety at posttreatment were significantly lower in PCBT than GCBT for youth with a primary diagnosis of separation anxiety disorder (RCMAS/P mean difference = −1.91, +/− margin of error (MOE) = 1.19, CR = −2.65, p < .01). There were no significant changes on the RCMAS from posttreatment to follow up for either treatment arm. However, there were significant posttreatment to follow up changes on the RCMAS/P for both GCBT (posttreatment mean = 8.42, SD = 5.79, follow up mean = 6.24, SD = 4.92, Cohen’s d = 0.44), and PCBT (posttreatment mean = 8.04, SD = 5.63, follow up mean = 6.09, SD = 5.68, Cohen’s d = 0.34), and with no significant difference between the two treatment arms, again suggesting comparable effects for the two treatments. The differential treatment outcome for separation anxiety disorder at posttreatment was not maintained at follow up. The magnitude of change in both treatments is comparable to prior efficacy trials and attests to the proper implementation of the two interventions.

Clinically significant change.

Clinically significant improvement was found on diagnostic recovery rates and CGAS ratings from pretreatment to posttreatment and from posttreatment to follow up as reflected by standard tests of proportions (see Table 1). Clinically significant improvement was also found on the CBCL-I, reflected by return to normative levels at posttreatment and follow up. There were no significant differences in these rates as a function of treatment arm.

Table 1.

Clinically Significant Change at Posttreatment and 12-month Follow Up: Percent of Youth not in Clinical Range

Posttreatment
12-month follow up
GCBT (n=83) PCBT (n=100) GCBT (n=83) PCBT (n=100)
Measures % % % %
ADIS: C/P Recovered from primary targeted diagnosis 67.9 74.7 82.1 87.9
CBCL-I Not in clinical range 75.0 81.4 84.1 79.2
C-GAS Not in clinical range 63.6 72.5 74.1 77.6

Note. All treatment differences in rates between GCBT and PCBT at a given time point were statistically non-significant based on logit regression adjusted for clustering. ADIS: C/P = Anxiety Disorders Interview Schedule, Child and Parent Versions; CBCL-I = Child Behavior Checklist – Internalizing; C-GAS = Children’s Global Assessment Scale.

Overview of Statistical Models

To evaluate models of treatment specificity, mediation of long-term recovery, and patterns of directionality of change, the data were analyzed using structural equation modeling focusing on treatment arm, the posttreatment measures, and the follow up measures. Pretreatment measures were represented as exogenous variables that served the role of statistical covariates (Rausch, Maxwell, & Kelley, 2003) A dummy variable for the two treatment arms (GCBT, PCBT) was defined (0 = GCBT; 1 = PCBT) and was assumed to directly impact youth anxiety and the mediators at posttreatment and 12-month follow up. The model included autoregressive, lagged (to assess temporal relation between mediators at posttreatment and anxiety at follow up; and between anxiety at posttreatment and mediators at follow up) and contemporaneous effects (see Figures 2 and 3). Three additional baseline covariates were included in the analysis because of their past association with anxiety, youth: (1) sex, (2) age, and (3) ethnicity. These covariates were included to increase statistical power for the outcome analyses and to reduce the need for correlated error parameters across time. Paths were included from each of these variables to all endogenous variables. We also included cross-sectional correlated error between the mediators to reflect their likely shared unmeasured common determinants. In both models, we assumed that the contemporaneous effect of the mediator on the outcome was comparable at the posttest and at the immediate follow up and introduced equality constraints between the paths, accordingly. Results for the SSRS and CBQ-NPYR mediators yielded non-significant results for the effects of the treatment arms on them, and their relationships to the outcomes. They were therefore excluded from the models and are not reported on further.

Figure 2.

Figure 2.

Youth Ratings SEM Model with Unstandardized Path Coefficients and Margin of Error

Figure 3.

Figure 3.

Parent Ratings SEM Model with Unstandardized Path Coefficients and Margin of Error

The tested models and the estimated path coefficients (half widths of 95% confidence intervals are presented as margins of error) appear in Figures 2 and 3. Figure 2 focuses on youth rated anxiety with youth rated mediators (i.e., Positive Peer Interactions, Social Skills, Psychological Control, Negative Parent-youth Relationship); figure 3 on parent rated youth anxiety with parent rated mediators (i.e., Positive Peer Interactions, Social Skills, Psychological Control, Negative Parent-youth Relationship). Both figures exclude sex, age, and ethnicity, and baseline exogenous variables (except treatment arm) to avoid clutter but these were included in all model tests. Residual terms across time were not correlated (when such correlations were included in the model during diagnostic checks, they were statistically non-significant). Although not expected, differential estimated effects (path coefficients) of each mediator on the outcome as a function of treatment arm and primary anxiety diagnosis were tested using interaction analysis with product terms. None of these effects were statistically significant and are not discussed further.

Initial analyses of the youth data revealed good model fit except for one omitted path as reflected by modification indices. This path linked perceived parental psychological control to positive peer interactions such that the more controlling children thought their parents were, the lower they tended to rate the quality of their peer interactions. This path makes theoretical sense, so it was included in the model (see Figure 2). To determine if the effect replicated with the parent data, we included it in the parent model (see Figure 3).

A variety of fit indices were used to evaluate global model fit, including the comparative fit index (CFI), the root mean square error of approximation (RMSEA), the p value for close fit (pClose), and the standardized root mean residual (SRMR). In addition, we examined focused tests of ill fit including modification indices and standardized residuals. Generally speaking, the models provided good fit to the data, with the exception that a direct path from baseline anxiety to anxiety at the follow up needed to be added to each model. The global fit statistics for the model in Figure 2 were chi square = 23.2, df = 16, p > .11; RMSEA = .05, pClose = .43; CFI = .98; SRMR = .03. For the model in Figure 3, they were chi square = 22.7, df = 16, p > .12; RMSEA = .05, pClose = .46; CFI = .99; SRMR = .02.

We orient presentation of results using the youth data, after which we highlight results that replicated and differed for the parent data.

Youth Data: Treatment Specificity and Mediation.

Treatment specificity effects in Figure 2 are reflected by the paths from the treatment dummy variable to the respective mediators. As predicted, youth ratings of perceived parental psychological control at posttreatment were lower in PCBT than GCBT (mean difference = −1.07, +/− MOE = 0.80, critical ratio [CR] = 2.64, p < .01), with lower levels of youths’ perceptions of parental psychological control being associated contemporaneously with lower levels of youth rated anxiety (path coefficient from control to anxiety = 0.33, MOE = 0.15, CR = 4.22, p < .01). Also as predicted, youth ratings of positive peer interactions at posttreatment were higher in GCBT than PCBT (mean difference = 3.51, MOE = 3.00, CR = 2.29, p < 0.03), with higher levels of positive peer interactions being associated, in turn, with lower levels of youth rated anxiety (path coefficient from positive peer interactions to anxiety = −0.08, MOE = 0.04, CR = 3.69, p < 0.01). Both of these results are consistent with treatment specificity effects. Given the opposing effects of treatment arm on the two mediators, the net result of no difference between GCBT and PCBT on youth anxiety, noted earlier, is not unexpected.

There is an important qualification to the above result, however. As seen in Figure 2, we also found evidence for a possible causal relation between the two mediators. Specifically, we observed a statistically significant estimated inverse effect of youths’ perceptions of their parental psychological control on positive peer interactions such that the more parents were perceived as controlling of their child, the less positively youths perceived their peer interactions (path coefficient = −0.99, MOE = 0.31, CR = 6.19, p < 0.01). Because the PCBT treatment yielded lower levels of parental control than GCBT, this contributed affirmatively to peer-youth positive interactions, ultimately reducing somewhat the advantage of GCBT in directly affecting positive peer interactions relative to PCBT.

The model in Figure 2 suggests several additional mediational dynamics that are of theoretical interest. First, there was a statistically significant lagged effect of treatment arm on positive peer interactions measured at follow up independent of the effects of treatment arm on peer interactions at posttreatment (path coefficient = −2.85, MOE = 2.76, CR = 2.03, p < 0.05). This result suggests that it takes time (in this case, up to 12 months) for some of the differential effects of the two treatments on positive peer interactions to manifest themselves. Interestingly, no such lagged dynamics were apparent for perceptions of parental psychological control, likely because parents can become less controlling more rapidly. Second, although the direct paths from the posttreatment mediators to anxiety as measured at follow up were not statistically significant, the mediators are still associated with follow up anxiety by virtue of their estimated indirect effects through the contemporaneous and autoregressive effects. For example, youths’ perceptions of parental psychological control at posttreatment was statistically significantly associated with parental psychological control at follow up, which, in turn, was linked to anxiety at the follow up. Similarly, positive peer interactions at posttreatment were statistically significantly associated with positive peer interactions at follow up, which, in turn, were inversely linked to anxiety at the follow up.

Direction of Change.

The models in Figure 2 and 3 preliminarily presume the directional pattern of change is from the mediators (perceived parental psychological control and positive peer interactions) to anxiety, but it is possible that reverse causal dynamics also operate between these variables. Of interest in this regard are the lagged paths from the mediators at posttreatment to the outcome at follow up, and the lagged paths from the outcome at posttreatment to the mediators at follow up. None of these paths were statistically significant, suggesting no reciprocal causality, at least over the 12 months spanning posttreatment to follow up. This does not, however, rule out the possibility of contemporaneous reciprocal causality at a given time point. For example, the estimated effect of perceived parental psychological control on anxiety was 0.33 at posttreatment (see Figure 2). However, this estimate presumes the causal direction is unidirectional. We added a contemporaneous reverse causal path between perceived parental psychological control and anxiety to the model in Figure 2 with an equality constraint for the path across the time intervals to make the model statistically identified. The path coefficient from perceived parental psychological control to anxiety remained statistically significant (path coefficient = 0.20, CR = 2.03, p < .05), as was the path coefficient from anxiety to perceived parental psychological control (path coefficient = 0.07, CR = 1.97, p < .05), suggesting the possible presence of contemporaneous reciprocal causality.

Parent Data.

There were some overlapping findings between the parent and youth data. As shown in Figure 3, parents’ ratings of positive peer interactions at posttreatment were higher in GCBT than PCBT (mean difference = 2.47, MOE = 2.43, CR = 1.99, p < .05), which is consistent with treatment specificity. However, the treatment difference for the perceived parental psychological control mediator was not statistically significant. As with the youth data, the model in Figure 3 suggests additional mediational dynamics of theoretical interest. There was a statistically significant estimated lagged effect of treatment arm on positive peer interactions measured at follow up independent of the effects of treatment arm on peer interactions at posttreatment (path coefficient = −3.03, MOE = 2.69, CR = 2.21, p < .03). This replicates what was observed for the youth data. Although the path coefficient from treatment dummy variable to perceived parental psychological control at posttreatment was not significant (contrary to what occurred for the youth data), there was a statistically significant estimated lagged effect from the treatment dummy variable to perceived parental psychological control at 12-month follow up. Unexpectedly, parents in GCBT rated themselves as less psychologically controlling compared with parents in PCBT at follow up even though parental psychological control was not targeted in GCBT. Finally, the possible presence of contemporaneous reciprocal causality was not found, unlike the youth data.

Discussion

As expected, GCBT and PCBT were similarly efficacious across youth and parent anxiety rating scales, diagnostic recovery rates, and return to normative comparisons. Our main interest was to move beyond therapeutic outcome and investigate issues that shed light on mechanisms that produce change in these two CBTs. As such, this is the first efficacy trial to examine treatment specificity of GCBT and PCBT. Our findings revealed GCBT had a larger effect on positive peer interactions at posttreatment relative to PCBT according to youth and parent ratings, supporting treatment specificity. Specificity was not found for GCBT’s other targeted peer variable, youth social skills. Although a small number of studies have examined treatment specificity of PCBT, the comparators in those studies were ICBT, not GCBT, and no evidence was found for PCBT specificity (i.e., parent variables changed even when not targeted in ICBT) (Jongerden & Bögels, 2014; Kendall et al., 2008; Silverman et al., 2009). We found some PCBT specificity: PCBT had a larger effect on perceived parental psychological relative to GCBT according to youth ratings. The other targeted variable, negative parent-youth relationships, did not show treatment specificity effects.

This is also the first study to report sustained treatment specificity effects. Sustained specificity effects were found again for positive peer interactions at 12-month follow up on both youth and parent ratings. It is likely that these treatment specificity effects were found because GCBT and PCBT had clear and distinct targeted peer and parent variables, respectively.

Coupled with their statistically significant relationships to anxiety, finding positive peer interactions changed more when targeted in GCBT and perceived parental psychological control changed more when targeted in PCBT suggests these variables are worthwhile to target in these respective CBTs, and prioritizing their inclusion/delivery in GCBTs and PCBTs may render both more efficacious over a full course of treatment. The same cannot be said for targeting youth socials skills in GCBT and negative youth-parent relationships in PCBT, neither of which showed mediation potential.

The variables that showed treatment specificity, positive peer interactions and perceived parental psychological control, also mediated contemporaneous anxiety outcomes. These findings provide insight into mechanisms by which GCBT and PCBT reduce anxiety in youths. Further study with more extensive timelines will be important to gain more nuanced understanding of the temporal dynamics of these mediation effects (Gaynor, 2017).

Another important finding in this trial and one that has been neglected in the treatment efficacy research literature, including youth anxiety, is the intriguing possibility that structural relationships exist amongst the mediators themselves, thereby complicating the theoretical tracing of relative treatment effects through treatment-specific mediators. For example, we observed a statistically significant estimated effect of perceived parental psychological control on positive peer interactions such that the more controlling parents were of their child, the lower the quality of peer interactions the child tended to have. In this sense, the PCBT arm, which lowered parental psychological control relative to GCBT, indirectly promoted a positive effect on peer relationships relative to GCBT by this reduced perceived parental control. Having said this, there also was evidence that GCBT improved positive peer interactions over and above this indirect effect of PCBT vis-a-vis other mechanisms.

Yet another important mediational dynamic observed, and neglected in the literature, were possible lagged effects on treatment specific mediators at follow up independent of any immediate posttreatment effects on the mediator. For example, the larger estimated effect of GCBT on positive peer interactions compared with PCBT became even more pronounced at 12 months than at immediate posttreatment. This suggests that among youth who complete treatment it may take a longer period before the GCBT activities fully translate into more positive peer interactions, an intriguing temporal dynamic to consider in future evaluations of GCBT.

Outcomes for GCBT and PCBT did not vary across informants (youth, parents, clinicians), with the exception of parents of children with separation anxiety disorder rating significantly lower anxiety in PCBT than GCBT. Weisz et al. (2017) in their meta-analysis found no significant effect of informant on anxiety treatment outcomes, though their analysis did not focus on anxiety subcategories or different CBT approaches. In contrast, as found in past PCBT research (Settipani et al., 2013; Silverman et al., 2009), mediation dynamics for long-term recovery, and patterns of directionality of change, varied by informants. Although there was no specificity on targeted parent variables using parent ratings, specificity was found using youth ratings. On one hand, these findings may represent once again the common occurrence of informant discrepancy, suggesting the potential utility of collecting data on measures that rely on different sources. On the other hand, the findings may represent meaningful and key differences in how parents and their children perceive their worlds, especially about something as personally salient as parenting behavior. These two “hands” are not necessarily mutually exclusive, highlighting the need for further research to unravel the complexities of multi-informant assessment approaches (Silverman & Ollendick, 2005).

Overall however our findings suggest clinicians may have flexibility and achieve similar anxiety reduction outcomes by targeting peer interactions in GCBTs, and parental psychological control in PCBTs. Similarly, addressing both of these mechanisms in the same intervention may result in additively superior effects than either one alone, a topic that should be addressed in future research. Importantly, our treatment specificity and mediation findings further suggest that clinicians might streamline CBTs for youth anxiety by removing procedures or components that do not contribute to outcome (social skills in GCBT, negative parent-youth relationships in PCBT), and focus more intensively on those that do contribute to outcome (peer interactions in GCBT, parental psychological control in PCBT).

Study Limitations and Future Research

There are several study limitations. One is the correlational nature of some of the analyses and assumptions that were necessitated about the timing of dynamics between cause and effects. Future research could employ more intensive and frequent measurement (Kraemer, Wilson, Fairburn, &, Agras, 2002). A second limitation is reliance on self-report data, though this was a reasonable place to begin this underdeveloped line of inquiry, and given the informant data suggest intriguing possibilities, as noted above. Third, although the efficacy of GCBT and PCBT are clearly established, history and maturational effects could be operating that are in part responsible for some of the changes observed across time. Subsequent studies that include a control arm would help clarify these issues. Fourth, although the high proportion of Hispanic/Latino participants is a study strength and past efficacy studies show Hispanic samples respond similarly to CBTs as non-Hispanic samples (Pina, Silverman, Fuentes, Kurtines, & Weems, 2003; Vaclavik et al., 2017), it is important for research to investigate generalizability.

Also relating to generalizability, because our study was designed to address efficacy-based issues surrounding theoretical mechanisms of change, we cannot assume the findings will generalize to effectiveness trials conducted in community settings. Indeed, unlike the relatively uniform pattern of positive outcomes in s youth anxiety efficacy trials in university-based research clinics, outcome effects in community clinics are lower and less consistent across studies (e.g., Bodden et al., 2008; Nauta, Scholing, Emmelkamp, & Minderaa, 2003). For example, a recent effectiveness trial found full recovery for only 23% of participants (Wergeland et al., 2014). Progress is being made to understand the conditions under which effectiveness CBT trials conducted in community clinic settings to reduce youth anxiety produce comparable outcomes to efficacy CBT trials conducted in clinical research settings (e.g., Southam-Gerow, Chorpita, Miller, & Gleacher, 2008). Such work requires an emphasis on understanding why participants do not complete treatment in community settings, as well as issues of treatment fidelity. Of note, youth anxiety efficacy trials have not revealed any consistent pattern of significant differences between treatment completers versus noncompleters (Kendall, & Sugarman, 1997; Pina, Silverman, Weems, Kurtines, & Goldman, 2003). Further research on both efficacy and effectiveness processes (i.e., how is change produced; how can treatment adherence and completion be enhanced) is needed.

Finally, as in any study that employs complicated statistical modeling approaches, omitted variable bias, bias due to possible correlated error, unmodeled reciprocal causality, biasing effects of measurement error, and equivalent/plausible model alternatives warrant consideration. Nevertheless, as one of the first studies to focus on rarely studied issues in efficacy trials, our findings lay the groundwork for further mechanism-based research, and carve out exciting new directions for designing, implementing, and analyzing trials that consider treatment specificity, mediation, directionality of change, lag effects in mediators, and causal and reciprocal influences amongst mediators.

References

  1. Achenbach TM (1991). Child behavior checklist/4–18. Burlington: University of Vermont, 5. 10.1590/S0102-311X2013000100004 [DOI] [Google Scholar]
  2. Alfano CA, Pina AA, Villalta IK, Beidel DC, Ammerman RT, & Crosby LE (2009). Mediators and moderators of outcome in the behavior treatment of childhood social phobia. Journal of the American Academy of Child and Adolescent Psychiatry, 48(9), 945–953. doi: 10.1097/CHI.0b013e3181af8216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Amercian Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author. [Google Scholar]
  4. Baldwin SA, Murray DM, & Shadish WR (2005). Empirically supported treatments or type I errors? Problems with the analysis of data from group-administered treatments. Journal of Consulting and Clinical Psychology, 73(5), 924–935. doi: 10.1037/0022-006X.73.5.924 [DOI] [PubMed] [Google Scholar]
  5. Barrett PM (1998). Evaluation of cognitive-behavioral group treatments for childhood anxiety disorders. Journal of Clinical Child Psychology, 27(4), 459–468. doi: 10.1207/s15374424jccp2704_10 [DOI] [PubMed] [Google Scholar]
  6. Beidel DC, Turner SM, & Morris TL (2000). Behavior treatment of childhood social phobia. Journal of Consulting and Clinical Psychology, 68(6), 1072–1080. [PubMed] [Google Scholar]
  7. Bierman KL, & McCauley E (1987). Children’s descriptions of their peer interactions – useful information for clinical child assessment. Journal of Clinical Child Psychology, 16(1), 9–18. doi: 10.1207/s15374424jccp1601_2 [DOI] [Google Scholar]
  8. Bird HR, Shaffer D, Fisher P, Gould MS, Staghezza B, Chen JY, & Hoven C (1993). The Columbia-Impairment-Scale (CIS) - Pilot findings on a measure of global impairment for children and adolescents. International Journal of Methods in Psychiatric Research, 3(3), 167–176. [Google Scholar]
  9. Bodden DH, Bogels SM, Nauta MH, de HE, Ringrose J, Appelboom C, et al. (2008). Child versus family cognitive-behavioral therapy in clinically anxious youth: an efficacy and partial effectiveness study. Journal of the American Academy of Child and Adolescent Psychiatry, 47(12), 1384–1394. [DOI] [PubMed] [Google Scholar]
  10. Breinholst S, Esbjorn BH, Reinholdt-Dunne ML, & Stallard P (2012). CBT for the treatment of child anxiety disorders: A review of why parental involvement has not enhanced outcomes. Journal of Anxiety Disorders, 26(3), 416–424. doi: 10.1016/j.janxdis.2011.12.014 [DOI] [PubMed] [Google Scholar]
  11. Chorpita BF, & Barlow DH (1998). The development of anxiety: the role of control in the early environment. Psychological bulletin, 124(1), 3–21. doi: 10.1037/0033-2909.124.1.3 [DOI] [PubMed] [Google Scholar]
  12. Dyrborg J, Larsen FW, Nielsen S, Byman J, Nielsen BB, & Gautre-Delay F (2000). The Children’s Global Assessment Scale (CGAS) and Global Assessment of Psychosocial Disability (GAPD) in clinical practice–substance and reliability as judged by intraclass correlations. European Child & Adolescent Psychiatry, 9(3), 195–201. doi: 10.1007/s007870070043 [DOI] [PubMed] [Google Scholar]
  13. Enders CK (2010). Applied missing data analysis. New York: Guilford Publications. [Google Scholar]
  14. Feinman RD (2009). Intention-to-treat. What is the question?. Nutrition & metabolism, 6(1), 1. doi: 10.1186/1743-7075-6-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Flannery-Schroeder EC, & Kendall PC (2000). Group and individual cognitive-behavioral treatments for youth with anxiety disorders: A randomized clinical trial. Cognitive Therapy and Research, 24(3), 251–278. doi: 10.1023/A:1005500219286 [DOI] [Google Scholar]
  16. Flay BR (1986). Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs. Prevention Medicine, 15, 451–474. [DOI] [PubMed] [Google Scholar]
  17. Gaynor ST (2017). Temporal precedence in the identification of mediators of change: A brief comment on “Mediators of change in the child/adolescent multimodal treatment study”(Kendall et al., 2016). doi: 10.1037/ccp0000108 [DOI] [PubMed] [Google Scholar]
  18. Ginsburg GS, Silverman WK, & Kurtines WK (1995). Family involvement in treating children with phobic and anxiety disorders: A look ahead. Clinical Psychology Review, 15(5), 457–473. doi: 10.1016/0272-7358(95)00026 [DOI] [Google Scholar]
  19. Greenwald P, Cullen JW (1985). The new emphasis in cancer control. Journal of the National Cancer Institute, 74, 543–551. [PubMed] [Google Scholar]
  20. Gresham FM, & Elliott SN (1990). Social skills rating system: Manual: American Guidance Service. [Google Scholar]
  21. Hale AE, Ginsburg GS, Chan G, Kendall PC, McCracken JT, Sakolsky D, … & Walkup JT (2018). Mediators of Treatment Outcomes for Anxious Children and Adolescents: The Role of Somatic Symptoms. Journal of Clinical Child & Adolescent Psychology, 47(1), 94–104. doi: 10.1080/15374416.2017.1280804 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Higa-McMillan CK, Francis SE, Rith-Najarian L, & Chorpita BF (2016). Evidence base update: 50 years of research on treatment for child and adolescent anxiety. Journal of Clinical Child and Adolescent Psychology, 45(2), 91–113. doi: 10.1080/15374416.2015.1046177 [DOI] [PubMed] [Google Scholar]
  23. Jongerden L, & Bögels SM (2014). Parenting, family functioning and anxiety-disordered children: Comparisons to controls, changes after family versus child CBT. Journal of Child and Family Studies, 24(7), 2046–2059. doi: 10.1007/s10826-014-0005-6 [DOI] [Google Scholar]
  24. Kazdin AE, Bass D, Ayers WA, & Rodgers A (1990). Empirical and clinical focus of child and adolescent psychotherapy research. Journal of Consulting and Clinical Psychology, 58(6), 729–740. doi: 10.1037/0022-006X.58.6.729 [DOI] [PubMed] [Google Scholar]
  25. Keeton CP, Ginsburg GS, Drake KL, Sakolsky D, Kendall PC, Birmaher B, Albano AM, March JS, Rynn M, Piacentini J & Walkup JT (2013). Benefits of child-focused anxiety treatments for parents and family functioning. Depression and Anxiety, 30, 865–872. doi: 10.1002/da.22055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kendall PC (1994). Treating anxiety disorders in children: results of a randomized clinical trial. Journal of Consulting and Clinical Psychology, 62(1), 100–110. doi: 10.1037/0022-006X.62.1.100 [DOI] [PubMed] [Google Scholar]
  27. Kendall PC, Cummings CM, Villabø MA, Narayanan MK, Treadwell K, Birmaher B, … & Gosch E (2016). Mediators of change in the Child/Adolescent Anxiety Multimodal Treatment Study. Journal of Consulting and Clinical Psychology, 84(1), 1. doi: 10.1037/a0039773 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kendall PC, Hudson JL, Gosch E, Flannery-Schroeder E, & Suveg C (2008). Cognitive-behavior therapy for anxiety disordered youth: A randomized clinical trial evaluating child and family modalities. Journal of Consulting and Clinical Psychology, 76(2), 282–297. doi: 10.1037/0022-006x.76.2.282 [DOI] [PubMed] [Google Scholar]
  29. Kendall PC, Olino TM, Carper M, & Makover H (2017). On the importance of temporal precedence in mediational analyses. Journal of Consulting and Clinical Psychology, 82(1), 80–82. doi: 10.1037/ccp0000152 [DOI] [PubMed] [Google Scholar]
  30. Kendall PC, & Sugarman A (1997). Attrition in the treatment of childhood anxiety disorders. Journal of Consulting and Clinical Psychology, 65, 883–888. [DOI] [PubMed] [Google Scholar]
  31. Kolko DJ, Brent DA, Baugher M, Bridge J, & Birmaher B (2000). Cognitive and family therapies for adolescent depression: Treatment specificity, mediation, and moderation. Journal of Consulting and Cclinical psychology, 68(4), 603. doi: 10.1037/0022-006X.68.4.603 [DOI] [PubMed] [Google Scholar]
  32. Kraemer HC, Wilson GT, Fairburn CG, & Agras WS (2002). Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry, 59(10), 877–883. doi: ynv10179 [pii]. [DOI] [PubMed] [Google Scholar]
  33. La Greca AM, Silverman WK, & Lochman JE (2009). Moving beyond efficacy and effectiveness in child and adolescent intervention research. Journal of Consulting and Clinical Psychology, 77, 373–382. doi: 10.1037/a0015954 [DOI] [PubMed] [Google Scholar]
  34. La Greca AM, & Landoll RR (2011). Peer influences. In Silverman WK & Field A (Ed.), Anxiety disorders in children and adolescents, Second edition (pp. 323–346). Cambridge, UK: Cambridge University Press. DOI: 10.1017/CBO9780511994920.016 [DOI] [Google Scholar]
  35. Lumpkin PW, Silverman WK, Weems CF, Markham MR, & Kurtines WM (2002). Treating a heterogeneous set of anxiety disorders in youth with group cognitive behavior therapy: A partially nonconcurrent multiple baseline evaluation. Behavior Therapy, 33, 163–177. [Google Scholar]
  36. Meuret AE, Rosenfiled D, Seidel A, Bhaskara L, & Hofmann SG (2010). Respiratory and cognitive mediators of treatment change in panic disorder: Evidence for intervention specificity. Journal of Consulting and Clinical Psychology, 78(5), 691–704. doi: 10.1037/a0019552 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mitka M (2012). FDA and pharma seek better ways to assess drug safety, efficacy in clinical trials. Journal of the American Medical Association, 307(24), 2576–2577. doi: 10.1001/jama.2012.6684 [DOI] [PubMed] [Google Scholar]
  38. Motoca LM, Williams S, & Silverman WK (2012). Social skills as a mediator between anxiety symptoms and peer interactions among children and adolescents. Journal of Clinical Child and Adolescent Psychology, 41, 329–336. doi: 0.1080/15374416.2012.668843 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Muthén LK, & Muthén B (1998–2012). Mplus User’s Guide. Seventh Edition. Los Angeles, CA: Muthén & Muthén. [Google Scholar]
  40. Nauta MH, Scholing A, Emmelkamp PMG, & Minderaa RB (2003). Cognitive behavioral therapy for children with anxiety disorders in a clinical setting: no additional effect of a cognitive parent training. Journal of the American Academy of Child and Adolescent Psychiatry, 42(11), 1270–1278. 10.1097/01.chi.0000085752.71002.93 [DOI] [PubMed] [Google Scholar]
  41. Peris TS, Compton SN, Kendall PC, Birmaher B, Sherrill J, March J, … & Keeton CP (2015). Trajectories of change in youth anxiety during cognitive—behavior therapy. Journal of Consulting and Clinical Psychology, 83(2), 239. doi: 10.1037/a0038402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Pina AA, Silverman WK, Fuentes RM, Kurtines WM, & Weems CF (2003). Exposure-based cognitive-behavior treatment for phobic and anxiety disorders: Treatment effects and maintenance for Hispanic/Latino relative to European-American youths. Journal of the American Academy of Child and Adolescent Psychiatry, 42(10), 1179–1187. doi: 10.1097/01.chi.0000081804.49840.02 [DOI] [PubMed] [Google Scholar]
  43. Pina AA, Silverman WK, Weems CF, Kurtines WM, & Goldman ML (2003). A comparison of completers and noncompleters of exposure-based cognitive and behavioural treatment for phobic and anxiety disorders in youth. Journal of Consulting and Clinical Psychology, 71, 701–705. doi: 10.1037/0022-006X.71.4.701 [DOI] [PubMed] [Google Scholar]
  44. Prinz RJ, Foster S, Kent RN, & O’Leary KD (1979). Multivariate assessment of conflict in distressed and nondistressed mother-adolescent dyads. Journal of Applied Behavior Analysis, 12(4), 691–700. doi: 10.1901/jaba.1979.12-691 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Rausch JR, Maxwell SE, & Kelley K (2003). Analytic methods for questions pertaining to a randomized pretest, post-treatment, follow-up design. Journal of Clinical Child and Adolescent Psychology, 32(3), 467–486. doi: 10.1207/S15374424jccp3203_15 [DOI] [PubMed] [Google Scholar]
  46. Reynolds CR, & Richmond BO (1978). What I think and feel: a revised measure of children’s manifest anxiety. Journal of Abnormal Child Psychol, 6(2), 271–280. doi: 10.1007/BF00919131 [DOI] [PubMed] [Google Scholar]
  47. Robin AL, & Foster SL (1989). Negotiating parent-adolescent conflict: A behavior systems approach. New York: Guilford. [Google Scholar]
  48. Schludermann E, & Schludermann J (1970). Replicability of factors in chidlren’s report of parent behavior (CRPBI). Journal of Psychology, 76(2), 239–249. doi: 10.1080/00223980.1970.9916845 [DOI] [Google Scholar]
  49. Schwarz JC, Barton-Henry ML, & Pruzinsky T (1985). Assessing child-rearing behaviors: a comparison of ratings made by mother, father, child, and sibling on the CRPBI. Child Development, 56(2), 462–479. doi: 10.2307/1129734 [DOI] [PubMed] [Google Scholar]
  50. Settipani CA, O’Neil KA, Podell JL, Beidas RS, & Kendall PC (2013). Youth anxiety and parent factors over time: directionality of change among youth treated for anxiety. Journal of Clinical Child and Adolescent Psychology, 42(1), 9–21. doi: 10.1080/15374416.2012.719459 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, & Aluwahlia S (1983). A children’s global assessment scale (CGAS). Archives of General Psychiatry, 40(11), 1228–1231. doi: 10.1001/archpsyc.1983.01790100074010 [DOI] [PubMed] [Google Scholar]
  52. Silverman WK, & Albano AM (1996). Anxiety Disorders Interview Schedule for Children-IV (Child and Parent Versions). New York: Oxford University Press [Google Scholar]
  53. Silverman WK, & Kurtines WM (1997). Theory in child psychosocial treatment research: Have it or had it? A pragmatic alternative. Journal of Abnormal Child Psychology, 25, 359–367. doi: 10.1023/A:1025780907141 [DOI] [PubMed] [Google Scholar]
  54. Silverman WK, Kurtines WM, Ginsburg GS, Weems CF, Lumpkin PW, & Carmichael DH (1999). Treating anxiety disorders in children with group cognitive-behaviorial therapy: A randomized clinical trial. Journal of Consulting and Clinical Psychology, 67(6), 995–1003. doi 10.1037//0022-006x.67.6.995 [DOI] [PubMed] [Google Scholar]
  55. Silverman WK, Kurtines WM, Jaccard J, & Pina AA (2009). Directionality of change in youth anxiety treatment involving parents: an initial examination. Journal of Consulting and Clinical Psychology, 77(3), 474–485. doi: 10.1037/a0015761 [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Silverman WK, & Ollendick TH (2005). Evidence-based assessment of anxiety and its disorders in children and adolescents. Journal of Clinical Child and Adolescent Psychology, 34(3), 380–411. doi: 10.1207/s15374424jccp34032 [DOI] [PubMed] [Google Scholar]
  57. Silverman WK, Pina AA, & Viswesvaran C (2008). Evidence-based psychosocial treatments for phobic and anxiety disorders in children and adolescents. Journal of Clinical Child and Adolescent Psychology, 37(1), 105–130. doi: 10.1080/15374410701817907 [DOI] [PubMed] [Google Scholar]
  58. Silverman WK, Saavedra LM, & Pina AA (2001). Test-retest reliability of anxiety symptoms and diagnoses with the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions. Journal of the American Academy of Child and Adolescent Psychiatry, 40(8), 937–944. doi: 10.1097/00004583-200108000-00016 [DOI] [PubMed] [Google Scholar]
  59. Southam-Gerow MA, Weisz JR, Chu BC, McLeod BD, Gordis EB, & Connor-Smith JK (2010). Does cognitive behavioral therapy for youth anxiety outperform usual care in community clinics? An initial effectiveness test. Journal of the American Academy of Child and Adolescent Psychiatry, 49(10), 1043–1052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Thulin U, Svirsky L, Serlachius E, Andersson G, & Ost LG (2014). The effect of parent involvement in the treatment of anxiety disorders in children: a meta-analysis. Cognitive Behavior Therapy, 43(3), 185–200. doi: 10.1080/16506073.2014.923928 [DOI] [PubMed] [Google Scholar]
  61. Treadwell KR, & Kendall PC (1996). Self-talk in youth with anxiety disorders: States of mind, content specificity, and treatment outcome. Journal of Consulting and Clinical Psychology, 64(5), 941. doi: 10.1037/0022-006X.64.5.941 [DOI] [PubMed] [Google Scholar]
  62. Vaclavik D, Buitron V, Rey Y, Marin CE, Silverman WK, & Pettit JW (2017). Parental acculturation level moderates outcome in peer-involved and parent-involved CBT for anxiety disorders in Latino youth. Journal of Latina/o Psychology, 5(4), 261–274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Walkup JT, Albano AM, Piacentini J, Birmaher B, Compton SN, Sherrill JT, … Kendall PC (2008). Cognitive behavior therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359(26), 2753–2766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Weisz JR, Kuppens S, Ng MY, Eckshtain D, Ugueto AM, Vaughn-Coaxum R, … & Weersing VR (2017). What five decades of research tells us about the effects of youth psychological therapy: A multilevel meta-analysis and implications for science and practice. American Psychologist, 72(2), 79–117. doi: 10.1037/a0040360 [DOI] [PubMed] [Google Scholar]
  65. Weersing VR, & Weisz JR (2002). Mechanisms of action in youth psychotherapy. Journal of Child Psychology and Psychiatry, 43(1), 3–29. doi: 10.1111/1469-7610.00002 [DOI] [PubMed] [Google Scholar]
  66. Wergeland GJH, Fjermestad KW, Marin CE, Haugland BSM, Bjaastad JF, Oeding K, & Heiervang ER (2014). An effectiveness study of individual vs. group cognitive behavioral therapy for anxiety disorders in youth. Behaviour Research and Therapy, 57, 1–12. doi: 10.1016/j.brat.2014.03.007 [DOI] [PubMed] [Google Scholar]
  67. Wood JJ, Piacentini JC, Bergman RL, McCracken J, & Barrios V (2002). Concurrent validity of the anxiety disorders section of the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions. Journal of Clinical Child and Adolescent Psychology, 31(3), 335–342. doi: 10.1207/S15374424JCCP3103 [DOI] [PubMed] [Google Scholar]

RESOURCES